Asymmetric Dimethylarginine, Race, and Mortality in Hemodialysis Patients
David A. Drew, Mark J. Sarnak(Tufts Medical Center), Tammy Scott(Brigham and Women's Hospital), Amy Kantor(Cancer Research And Biostatistics), Hocine Tighiouart(Tufts University), Carlo Alberto Artusi(University of Turin), Mario Plebani(University of Padua), Li Fan(Wenzhou Medical University), Daniel E. Weiner(Tufts Medical Center)
Cited by 16
Related Papers
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
|New England Journal of Medicine|2012|4.1k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality
|Journal of the American Society of Nephrology|2004|1.2k